Long-Term Care Facilities Face Growing Challenges Accommodating Medical Marijuana

As medical marijuana gains legal access in 30 states, long-term care facilities and senior care pharmacists face a complex regulatory landscape in accommodating resident requests while navigating federal prohibition and varying state laws.

RTHC-01876ReviewPreliminary Evidence2018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Medical marijuana use is growing among long-term care residents. Facilities face unique challenges including federal illegality (affecting Medicare/Medicaid facilities), state-by-state regulatory variation, the difference between plant-derived and synthetic products, and the need for pharmacist guidance. Some facilities are developing accommodation policies despite the legal quagmire.

Key Numbers

30 states had approved medical marijuana at time of publication. Two FDA-approved synthetic cannabinoids (for chemotherapy nausea and AIDS appetite). Plant-derived products differ from synthetics in multiple ways.

How They Did This

Review of the regulatory landscape, pharmacological considerations, and practical challenges of medical marijuana in long-term care and senior care pharmacy settings.

Why This Research Matters

The growing population of older adults using medical cannabis creates unique challenges in institutional settings where federal funding, drug interactions, and cognitive effects must all be considered alongside state-level legalization.

The Bigger Picture

The collision of federal prohibition with expanding state legalization creates a particularly acute problem in long-term care, where facilities must comply with federal regulations to maintain Medicare/Medicaid funding while also responding to state laws and patient needs.

What This Study Doesn't Tell Us

Practical review rather than systematic analysis. Rapidly changing legal landscape means specific guidance becomes outdated quickly. Limited evidence specifically in elderly populations.

Questions This Raises

  • ?How should long-term care facilities balance federal compliance with state law?
  • ?What are the specific drug interaction risks for elderly patients on multiple medications?
  • ?Could federal rescheduling resolve the institutional challenges?

Trust & Context

Key Stat:
30 states have approved medical marijuana, but long-term care facilities receiving federal funding face a legal conflict that complicates accommodation.
Evidence Grade:
Preliminary - practical review of regulations and challenges rather than systematic evidence analysis.
Study Age:
Published in 2018. The regulatory landscape has continued to evolve significantly.
Original Title:
Increased Use of Medical Marijuana: Skepticism vs. Evidence.
Published In:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 33(12), 680-689 (2018)
Database ID:
RTHC-01876

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Can nursing home residents use medical marijuana?

It depends on state law and facility policy. While 30 states had legalized medical marijuana at the time of this review, long-term care facilities face unique challenges including federal funding requirements and varying state regulations. Some facilities are developing accommodation policies.

What challenges do pharmacists face with medical marijuana in senior care?

Pharmacists must navigate federal illegality versus state legalization, lack of standardized dosing for elderly patients, potential drug interactions with common medications, and the differences between FDA-approved synthetic cannabinoids and plant-derived products.

Read More on RethinkTHC

Cite This Study

RTHC-01876·https://rethinkthc.com/research/RTHC-01876

APA

Wick, Jeannette Y. (2018). Increased Use of Medical Marijuana: Skepticism vs. Evidence.. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 33(12), 680-689. https://doi.org/10.4140/TCP.n.2018.680.

MLA

Wick, Jeannette Y. "Increased Use of Medical Marijuana: Skepticism vs. Evidence.." The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2018. https://doi.org/10.4140/TCP.n.2018.680.

RethinkTHC

RethinkTHC Research Database. "Increased Use of Medical Marijuana: Skepticism vs. Evidence." RTHC-01876. Retrieved from https://rethinkthc.com/research/wick-2018-increased-use-of-medical

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.